Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine Infusion in Sepsis and Septic Shock
NCT04130230Phase 2Completed
- Sponsor
- Mansoura University
- Start
- Mar 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of neostigmine in sepsis, septic shock, sponsored by Mansoura University. Started Mar 2019; status: completed.
02
Drugs
neostigmine
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT04130230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04130230.